Julien D.
- Country
- France
- Department
- N/A
Research Overview
- Oral semaglutide versus placebo in early Alzheimer’s disease: a randomized double-blind trial in patients with mild cognitive impairment or mild dementia
- Evaluation of Donepezil Versus Non-Pharmacological Management in Patients with Alzheimer's Disease: A Randomized Controlled Trial
- Efficacy and Safety Evaluation of Mirodenafil Dihydrochloride in Early Alzheimer's Disease: A Phase 3 Double-Blind, Randomized, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 105 of 174 partner sites.
Specializations
Neurodegenerative Disorders
The investigator specializes in studying early-stage Alzheimer's disease and its clinical manifestations, with particular emphasis on mild cognitive impairment (MCI) and mild dementia.
- Cognitive Function Assessment
- Dementia Rating Evaluation
- Early Disease Intervention
Their research encompasses cognitive decline progression and therapeutic interventions in early-stage neurodegeneration.
Therapeutic Approaches
The investigator focuses on evaluating both pharmacological treatments and non-drug management strategies for Alzheimer's disease, including the assessment of medications like donepezil and semaglutide.
- Standard of Care Optimization
- Combination Therapy Assessment
- Treatment Pathway Development
Their work explores comparative effectiveness of different therapeutic interventions in neurodegenerative conditions.
Clinical Assessment
The investigator conducts research on cognitive efficiency measurement and clinical outcomes assessment in neurodegenerative disorders, utilizing standardized rating scales and evaluation methods.
- Long-term Efficacy Monitoring
- Safety Profile Evaluation
- Treatment Response Assessment
Their expertise includes longitudinal assessment of disease progression and therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.